This is a major presentation on a major trial for advanced prostate cancer patients that was just released this week.
Through my website and the UsTOO chapter I run, I have arranged a webinar for the CHAARTED clinical trial. The presenter will be Dr/ Nicholas Vogelzang who is a co-author of the Sweeney et al paper. The seats are limited and the moderator will be yours truly.
I will limit the attendance but I may
open it up beyond the 25 available I have today. Questions must be submitted in advance and PCAF sign in is needed. I may
open the presentation up to 200 and to ten live questions.
Please stay tuned as I have to arrange the sign in methods and I will work on it this weekend.
PCAF : Prostate Cancer Advocates Forum.
CHAARTED means: Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa)
More information will be posted here:advancedpcatalk.freeforums.net/thread/123/chaarted-presentation-pcaf-june-00pm
Please stay tuned. I have to circle the wagons with the PCAF staff members and get the final plans set.